News for 'Lopinavir'

Remdesivir didn't cut mortality in Covid patients: WHO

Remdesivir didn't cut mortality in Covid patients: WHO

Rediff.com16 Oct 2020

The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.

Govt recommends anti-HIV drug for some COVID-19 patients

Govt recommends anti-HIV drug for some COVID-19 patients

Rediff.com17 Mar 2020

There is no current evidence from randomised controlled trial to recommend any specific treatment for suspected or confirmed patients with COVID-19.

Govt may remove plasma therapy as COVID-19 treatment

Govt may remove plasma therapy as COVID-19 treatment

Rediff.com20 Oct 2020

A trial has shown that plasma therapy does not reduce mortality or prevent progression of COVID-19.

Health min recommends anti-malarial drug for COVID-19

Health min recommends anti-malarial drug for COVID-19

Rediff.com31 Mar 2020

The ministry has removed its earlier recommendation of the use of anti-HIV drug combinations Lopinavir and Ritonavir on a case-to-case basis depending upon the severity of the condition of a patient suffering from coronavirus infection.

Cipla working on multiple therapies to fight spread of COVID

Cipla working on multiple therapies to fight spread of COVID

Rediff.com18 May 2020

Cipla is among the three Indian companies that signed a non-exclusive licensing agreement with US-based Gilead Sciences to make and distribute the latter's repurposed Ebola drug Remdesivir in 127 countries including India.

No new COVID-19 cases in 9 states, UTs in last 24 hrs

No new COVID-19 cases in 9 states, UTs in last 24 hrs

Rediff.com13 May 2020

The rate of doubling of COVID-19 cases has increased to 12.6 days

Life saving move! India rejects Abbot's HIV drug patent

Life saving move! India rejects Abbot's HIV drug patent

Rediff.com3 Jan 2011

India has rejected a drug patent application of a United States multinational pharma company, paving the way for easy access to an important life-saving medication for HIV patients across the globe.

12 more coronavirus cases in India, total 58

12 more coronavirus cases in India, total 58

Rediff.com10 Mar 2020

In Jaipur, the combination of lopinavir and ritonavir, both second-line HIV drugs, was administered was administered on an elderly Italian couple undergoing treatment for Covid-19 at the SMS Hospital.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

COVID-19: The threat from people with no symptoms

COVID-19: The threat from people with no symptoms

Rediff.com14 May 2020

'Testing is a very good strategy if only symptomatic people are transmitting the disease.' 'Here asymptomatic people, with minimum, trivial symptoms, are transmitting too.' 'Testing, treating, tracing contacts and quarantining them -- yes, it will work up to a certain extent.' 'But more important is physical distancing, hand hygiene, cough etiquette and cocooning, protecting with reverse quarantining the most vulnerable people, senior citizens, people with other major medical problems.' 'To me, that makes much more sense.'

'COVID-19 is deadly in 0.1 per cent people'

'COVID-19 is deadly in 0.1 per cent people'

Rediff.com20 Oct 2020

'Some of the longer-term implications of COVID-19 are not related to the virus itself.' 'They are actually related to immune responses from the virus.'

'Cases will be around for 6 to 9 months'

'Cases will be around for 6 to 9 months'

Rediff.com16 Apr 2020

'The only idea -- the only idea -- of the shutdown was to buy time.'

'COVID-19 will be a year-long struggle'

'COVID-19 will be a year-long struggle'

Rediff.com18 May 2020

'Predictions are that numbers will continue to rise till May end and maybe in the first half of June will be our peak.'

India set to run out of critical free drug for HIV/AIDS programme

India set to run out of critical free drug for HIV/AIDS programme

Rediff.com2 Oct 2014

The country had the third-largest number of people living with disease.